Taipei, July 17 (CNA) A new study by Taiwan's National Health Research Institute (NHRI) has identified a link between CLEC2, a C-type lectin-like type II transmembrane receptor, and thromboinflammation, the major cause of morbidity and mortality in COVID-19 patients.